Cefoperazone

Cefoperazone
Systematic (IUPAC) name
(6R,7R)-7-[(2R)-2-{[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a601206
Pharmacokinetic data
Excretion Hepatic
Identifiers
CAS Number 62893-19-0 YesY
ATC code J01DD12 QJ51DD12
PubChem CID 44185
DrugBank DB01329 YesY
ChemSpider 40206 YesY
UNII 7U75I1278D YesY
KEGG D07645 YesY
ChEMBL CHEMBL507674 YesY
Chemical data
Formula C25H27N9O8S2
Molar mass 645.67 g/mol
  (verify)

Cefoperazone is a third-generation cephalosporin antibiotic, marketed by Pfizer under the name Cefobid. It is one of few cephalosporin antibiotics effective in treating Pseudomonas bacterial infections which are otherwise resistant to these antibiotics.

Cefoperazone is also sold as a co-formulation with sulbactam. Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis, and sulbactam acts as a beta-lactamase inhibitor, to increase the antibacterial activity of cefoperazone against beta-lactamase-producing organisms.

Spectrum of bacterial susceptibility

Cefoperazone has a broad spectrum of activity and has been used to target bacteria responsible for causing infections of the respiratory and urinary tract, skin, and the female genital tract. The following represents MIC susceptibility data for a few medically significant microorganisms.

[1][2]

Adverse effects

Cefoperazone contains an N-methylthiotetrazole (NMTT or 1-MTT) side chain. As the antibiotic is broken down in the body, it releases free NMTT, which can cause hypoprothrombinemia (likely due to inhibition of the enzyme vitamin K epoxide reductase) and a reaction with ethanol similar to that produced by disulfiram (Antabuse), due to inhibition of aldehyde dehydrogenase.[3]

Synthesis

Cefoperazone synthesis:[4]

References

  1. http://antibiotics.toku-e.com/antimicrobial_462_1.html
  2. http://www.toku-e.com/Assets/MIC/Cefoperazone%20sodium.pdf
  3. Stork CM (2006). "Antibiotics, antifungals, and antivirals". In Nelson LH, Flomenbaum N, Goldfrank LR, Hoffman RL, Howland MD, Lewin NA (eds.). Goldfrank's toxicologic emergencies. New York: McGraw-Hill. p. 847. ISBN 0-07-143763-0. Retrieved 2009-07-03.
  4. I. Saikawa, S. Takano, Y. Shuntaro, C. Yoshida, 0.Takashima, K. Momonoi, S. Kuroda, M. Komatsu, T. Yasuda,and Y. Kodama, DE 2600880 (1977); Chem.Abstr., 87_, 184533b (1977).
This article is issued from Wikipedia - version of the Thursday, November 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.